Frank J. Fabio
Direttore Finanziario/CFO presso CERES VENTURES, INC.
Posizioni attive di Frank J. Fabio
Società | Posizione | Inizio | Fine |
---|---|---|---|
CERES VENTURES, INC. | Direttore Finanziario/CFO | 29/04/2013 | - |
Storia della carriera di Frank J. Fabio
Precedenti posizioni note di Frank J. Fabio
Società | Posizione | Inizio | Fine |
---|---|---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Direttore Finanziario/CFO | 12/09/2008 | 09/01/2009 |
Segretario Aziendale | 12/09/2008 | 09/01/2009 | |
RENOVACARE, INC. | Direttore Finanziario/CFO | 12/09/2008 | 09/01/2009 |
Segretario Aziendale | 12/09/2008 | 09/01/2009 | |
SOLARWINDOW TECHNOLOGIES, INC. | Direttore Finanziario/CFO | 09/09/2008 | 09/01/2009 |
Segretario Aziendale | 09/09/2008 | 09/01/2009 | |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Direttore Finanziario/CFO | - | 14/11/2007 |
Segretario Aziendale | - | 14/11/2007 |
Formazione di Frank J. Fabio
Pace University | Undergraduate Degree |
Long Island University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Director of Finance/CFO | 5 |
Corporate Secretary | 4 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
RENOVACARE, INC. | Health Technology |
SOLARWINDOW TECHNOLOGIES, INC. | Producer Manufacturing |
CERES VENTURES, INC. | Health Services |
Aziende private | 2 |
---|---|
NDB Energy, Inc.
NDB Energy, Inc. Financial ConglomeratesFinance NDB Energy, Inc. is in the process of locating new commercial opportunities. The company is currently not engaged in any business operations. It is in the process of attempting to identify, locate and if warranted, acquire new commercial opportunities. The company was founded on November 6, 1998 and is headquartered in Washington, DC. | Finance |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
- Borsa valori
- Insiders
- Frank J. Fabio
- Esperienza